Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Pregabalin and Duloxetine in Patients With Painful Diabetic Peripheral Neuropathy (PDPN): the Effect of Pain on Cognitive Function, Sleep and Quality of Life (BLOSSOM)

NCT04246619 is registered in ClinicalTrials.gov with KRKA as lead sponsor.

NCT NCT04246619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04246619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Pregabalin and Duloxetine in Patients With Painful Diabetic Peripheral Neuropathy (PDPN): the Effect of Pain on Cognitive Function, Sleep and Quality of Life (BLOSSOM)
Lead sponsor
KRKA
Phase
Phase 4
Overall status
Terminated
Start date
November 12, 2019
Completion date
December 21, 2021
Enrollment
254 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

painful diabetic peripheral neuropathy